Botanix Pharmaceuticals Limited (BOT) Stock Statistics & Valuation Metrics

Botanix Pharmaceuticals Limited has a market cap or net worth of AU$57.42M. The enterprise value is AU$44.88M.

Botanix Pharmaceuticals Limited has 2,734,312,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Botanix Pharmaceuticals Limited’s return on equity (ROE) is -1.06 and return on invested capital (ROIC) is -70.96%.

The current PE Ratio of Botanix Pharmaceuticals Limited is ―. Botanix Pharmaceuticals Limited’s PEG ratio is -0.02.

In the last 12 months, Botanix Pharmaceuticals Limited had revenue of 5.79M and earned -86.40M in profits. Earnings per share was -0.05.

In the last 12 months, operating cash flow was -80.66M and capital expenditures -198.17K, giving a free cash flow of -80.86M billion.

Botanix Pharmaceuticals Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Botanix Pharmaceuticals Limited upcoming earnings date is Aug 28, 2026, TBA (Confirmed).

Botanix Pharmaceuticals Limited as a current ratio of 4.00, with Debt / Equity ratio of 56.80%

In the past 12 months, Botanix Pharmaceuticals Limited has paid -31.92K in taxes.

Botanix Pharmaceuticals Limited EV to EBITDA ratio is -6.92, with an EV/FCF ratio of -7.07.

Botanix Pharmaceuticals Limited has AU$31.61M in cash and marketable securities with AU$30.67M in debt, giving a net cash position of AU$942.97K billion.

Gross margin is -118.23%, with operating margin of -1395.62%, and net profit margin of -1492.37%.

The average price target for Botanix Pharmaceuticals Limited is AU$0.57, which is 11.43% higher than the current price. The consensus rating is Moderate Buy